Trial Profile
Study of Actemura Remission induction of RA and Sequential Maintenance of Remission by Reasonable cost Treatment
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Bucillamine; Tacrolimus
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms STARR-SMARRT
- 27 Dec 2016 Status changed from recruiting to discontinued.
- 28 Jan 2014 New trial record